Single-cell analysis reveals insights into immune responses during xenotransplantation

FHS
May 22, 2024
6:59 pm

Surgical teams at NYU Langone Health performed the world’s first genetically modified pig kidney transplants into a human body in September and November 2021, and then transplanted two pig hearts in the summer of 2022.

Patients with asthma and other inflammatory lung diseases can be treated ‘in a fundamentally new way’

Arrowhead Pharmaceuticals Inc. has announced interim results from an ongoing phase 1/2 clinical study of ARO-RAGE, an investigational RNA interference (RNAi) therapeutic designed to reduce

April 27, 2023

Pfizer’s $1.5B cuts; Biogen’s $1.15B buyout; AstraZeneca’s $80B ambition; RNA startup merger; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit

May 26, 2024

What to know about this year’s Medicare open enrollment period

It’s the middle of October — the time of year that’s filled with pumpkin spice lattes, jumbo-sized bags of Halloween candy, and endless advertisements to

October 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.